Company Disclosure

Trident Lifeline Limited (Scrip Code: 543616) has submitted a regulatory disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, dated June 16, 2026.

Nature of Event

This disclosure concerns a private placement of equity shares conducted by Trident Mediquip Limited (CIN: U33309GJ2019PLC110421), a subsidiary company of Trident Lifeline Limited. The placement was made to other shareholders, resulting in a change in the parent company's shareholding percentage.

Shareholding Impact

Following the private placement allotment:

  • Pre-allotment holding: 58.84%
  • Post-allotment holding: 58.67%

The holding decreased by 0.17 percentage points due to the dilution from the private placement to other shareholders.

Subsidiary Company Details

Trident Mediquip Limited is incorporated under the Companies Act, 2013 with its registered office in Surat, Gujarat.

Capital Structure:

  • Authorized Share Capital: ₹10,00,00,000 divided into 1,00,00,000 equity shares of ₹10 each
  • Paid-up Share Capital: ₹10,00,00,000 divided into 1,00,00,000 equity shares of ₹10 each

Financial Performance:

  • FY 2023-24 Turnover: ₹20.58 crore
  • FY 2024-25 Turnover: ₹21.29 crore
  • FY 2025-26 Turnover: ₹27.31 crore

Related Party Transaction

This transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. Several individuals associated with the promoter/promoter group/board of Trident Lifeline Limited have interests in the entity being acquired:

  • Mr. Amit Bhupendra Halvawala (Director's Relative of Rupaben Jariwala)
  • Mr. Chetan Chandrakant Jariwala (Director's Relative of Rupaben Jariwala)
  • Mr. Hardik Jigishkumar Desai (Member)

The company states that the transaction was conducted on an "arm's length basis."

Industry Classification

The subsidiary operates in the Medical Device Industry and has presence exclusively in India.

Transaction Details

The disclosure indicates that no governmental or regulatory approvals were required for this acquisition (marked as "NA"). Similarly, no indicative time period for completion, consideration details, cost of acquisition, or price at which shares were acquired were provided in the disclosure.

Company Background

Trident Mediquip Limited was incorporated on October 19, 2019, and has shown consistent turnover growth over the past three financial years.

Document Signatory: Nikita Sharma, Company Secretary and Compliance Officer (Membership No.: A60595)